Use of proteomics to detect sex-related differences in effects of toxicants: implications for using proteomics in toxicology

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

This review provides an overview of results obtained when using proteome analysis for detecting sex-based differences in response to toxicants. It reveals implications to be taken into account when considering the use of proteomics in toxicological studies. It appears that results may differ when studying the same chemical in the same species in different target tissues. Another result of interest is the limited dose-response behavior of differential abundance patterns observed in studies where more than one dose level is tested. It is concluded that use of proteomics to study differences in modes of action of toxic compounds is an active area of research. The examples from use of proteomics to study sex-dependent differences also reveal that further studies are needed to provide reliable insight in modes of action, novel biomarkers or even novel therapies. To eventually reach this aim for this and other toxicological endpoints, it is essential to consider background variability, consequences of timing of toxicant administration, dose-response behavior, relevant species and target organ, species and organ variability and the presence of proteoforms.

Original languageEnglish
Pages (from-to)666-681
JournalCritical Reviews in Toxicology
Volume48
Issue number8
DOIs
Publication statusPublished - 14 Sep 2018

Fingerprint

Sex Characteristics
Proteomics
Toxicology
Toxic Actions
Biomarkers
Proteome
Tissue
Research
Therapeutics

Keywords

  • mode of action
  • proteomics
  • Sex related differences
  • state-of-the-art
  • toxicants

Cite this

@article{ade102348c494ee6abd0306f72818300,
title = "Use of proteomics to detect sex-related differences in effects of toxicants: implications for using proteomics in toxicology",
abstract = "This review provides an overview of results obtained when using proteome analysis for detecting sex-based differences in response to toxicants. It reveals implications to be taken into account when considering the use of proteomics in toxicological studies. It appears that results may differ when studying the same chemical in the same species in different target tissues. Another result of interest is the limited dose-response behavior of differential abundance patterns observed in studies where more than one dose level is tested. It is concluded that use of proteomics to study differences in modes of action of toxic compounds is an active area of research. The examples from use of proteomics to study sex-dependent differences also reveal that further studies are needed to provide reliable insight in modes of action, novel biomarkers or even novel therapies. To eventually reach this aim for this and other toxicological endpoints, it is essential to consider background variability, consequences of timing of toxicant administration, dose-response behavior, relevant species and target organ, species and organ variability and the presence of proteoforms.",
keywords = "mode of action, proteomics, Sex related differences, state-of-the-art, toxicants",
author = "Rietjens, {Ivonne M.C.M.} and Jacques Vervoort and Anna Maslowska-G{\'o}rnicz and {Van den Brink}, Nico and Karsten Beekmann",
year = "2018",
month = "9",
day = "14",
doi = "10.1080/10408444.2018.1509941",
language = "English",
volume = "48",
pages = "666--681",
journal = "Critical Reviews in Toxicology",
issn = "1040-8444",
publisher = "Taylor & Francis",
number = "8",

}

Use of proteomics to detect sex-related differences in effects of toxicants : implications for using proteomics in toxicology. / Rietjens, Ivonne M.C.M.; Vervoort, Jacques; Maslowska-Górnicz, Anna; Van den Brink, Nico; Beekmann, Karsten.

In: Critical Reviews in Toxicology, Vol. 48, No. 8, 14.09.2018, p. 666-681.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Use of proteomics to detect sex-related differences in effects of toxicants

T2 - implications for using proteomics in toxicology

AU - Rietjens, Ivonne M.C.M.

AU - Vervoort, Jacques

AU - Maslowska-Górnicz, Anna

AU - Van den Brink, Nico

AU - Beekmann, Karsten

PY - 2018/9/14

Y1 - 2018/9/14

N2 - This review provides an overview of results obtained when using proteome analysis for detecting sex-based differences in response to toxicants. It reveals implications to be taken into account when considering the use of proteomics in toxicological studies. It appears that results may differ when studying the same chemical in the same species in different target tissues. Another result of interest is the limited dose-response behavior of differential abundance patterns observed in studies where more than one dose level is tested. It is concluded that use of proteomics to study differences in modes of action of toxic compounds is an active area of research. The examples from use of proteomics to study sex-dependent differences also reveal that further studies are needed to provide reliable insight in modes of action, novel biomarkers or even novel therapies. To eventually reach this aim for this and other toxicological endpoints, it is essential to consider background variability, consequences of timing of toxicant administration, dose-response behavior, relevant species and target organ, species and organ variability and the presence of proteoforms.

AB - This review provides an overview of results obtained when using proteome analysis for detecting sex-based differences in response to toxicants. It reveals implications to be taken into account when considering the use of proteomics in toxicological studies. It appears that results may differ when studying the same chemical in the same species in different target tissues. Another result of interest is the limited dose-response behavior of differential abundance patterns observed in studies where more than one dose level is tested. It is concluded that use of proteomics to study differences in modes of action of toxic compounds is an active area of research. The examples from use of proteomics to study sex-dependent differences also reveal that further studies are needed to provide reliable insight in modes of action, novel biomarkers or even novel therapies. To eventually reach this aim for this and other toxicological endpoints, it is essential to consider background variability, consequences of timing of toxicant administration, dose-response behavior, relevant species and target organ, species and organ variability and the presence of proteoforms.

KW - mode of action

KW - proteomics

KW - Sex related differences

KW - state-of-the-art

KW - toxicants

U2 - 10.1080/10408444.2018.1509941

DO - 10.1080/10408444.2018.1509941

M3 - Review article

VL - 48

SP - 666

EP - 681

JO - Critical Reviews in Toxicology

JF - Critical Reviews in Toxicology

SN - 1040-8444

IS - 8

ER -